Abiopharma

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast

Mirum Pharma - Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital

Volixibat Data from Mirum’s VANTAGE PBC Study Showcased at EASL

Johnson & Johnson - Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis

Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada